Cancer associates with risk and severe events of COVID ‐19: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer associates with risk and severe events of COVID ‐19: A systematic review and meta‐analysis

Published:2020-08-15 Issue:2 Volume:148 Page:363-374
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Tian Yehong¹,Qiu Xiaowei¹,Wang Chengxiang¹,Zhao Jianxin¹,Jiang Xin¹,Niu Wenquan²,Huang Jinchang¹^ORCID,Zhang Fengyu³⁴

Affiliation:

1. The Third Affiliated Hospital, Beijing University of Chinese Medicine Beijing China

2. Institute of Clinical Medical Sciences, China‐Japan Friendship Hospital Beijing China

3. Beijing Huilongguan Hospital & Peking University Huilongguan Clinical Medical School Beijing China

4. Global Clinical and Translational Research Institute Bethesda Maryland USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33213

Reference63 articles.

1. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

2. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)

3. Immune-epidemiological parameters of the novel coronavirus – a perspective

4. Clinical Characteristics of Coronavirus Disease 2019 in China

5. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors;2024-07-23

2. Adjusting laser power to control the heat generated by nanoparticles at the site of a patient's cells;IET Systems Biology;2024-05-24

3. Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19;Frontiers in Immunology;2024-04-17

4. Work ability and mental health at return to work after COVID-19: A descriptive study among healthcare workers;Work;2024-03-10

5. Infectious Diseases;Advances in Neurobiology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3